Short Selling SNGX’s 75% Morning Spike – $400 in 1 Hour.

SNGX (Soligenix Inc.) jumped nearly 75% on news relating to their new ricin toxin vaccine development program’s efficacy results. Although promising, this product is years away from any commercialization, and their potential market is very limited. Paired with unhealthy financials and a dramatic technical over-extension, a crash was imminent.